IRIS

Sfoglia per Rivista  LANCET NEUROLOGY

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 35 a 54 di 66
Titolo Data di pubblicazione Autore(i) File
KIR 4.1: another misleading expectation in multiple sclerosis? 1-gen-2014 Filippi, Massimo; Rocca, Ma; Lassmann, H.
lomg-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5 year active treatment extension of the phase 2 BENEFIT trial 1-gen-2009 Kappos, L; Freedman, Ms; Polman, Ch; EDAN G., HARTUUNG HP; Miller, Dh; Montalban, X; Barkhof, F; Radu, Ew; Metzig, C; Bauer, L; Lanius, V; Sandbrink, R; Comi, Giancarlo
Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study 1-gen-2011 Oertel, W; Trenkwalder, C; Beneš, H; Ferini Strambi, L; Högl, B; Poewe, W; Stiasny-Kolster, K; Fichtner, A; Schollmayer, E; Kohnen, R; García-Borreguero, D
MRI criteria for dissemination in space in patients with clinically isolated syndromes: a multicentre follow-up study 1-gen-2006 Korteweg, T; Tintore, M; Uitdehoog, B; Rovira, A; Frederiksen, J; Miller, D; Fernando, K; Filippi, M; Agosta, F; Rocca, M; Fazekas, F; Enzinger, C; Matthews, P; Parry, A; Polman, C; Montalban, X; Barkhof, F
MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study 1-gen-2007 Swanton, Jk; Rovira, A; Tintore, M; Altmann, Dr; Barkhof, F; Filippi, Massimo; Huerga, E; Miszkiel, Ka; Plant, Gt; Polman, C; Rovaris, M; Thompson, Aj; Montalban, X; Miller, Dh
MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines 1-gen-2016 Filippi, M; Rocca, Ma; Ciccarelli, O; De Stefano, N; Evangelou, N; Kappos, L; Rovira, A; Sastre-Garriga, J; Tintorè, M; Frederiksen, Jl; Gasperini, C; Palace, J; Reich, Ds; Banwell, B; Montalban, X; Barkhof, F
MRI in multiple sclerosis: current status and future prospects 1-gen-2008 Bakshi, R; Thompson, Aj; Rocca, Ma; Pelletier, D; Dousset, V; Bakhof, F; Inglese, M; Guttman, C; Horsfield, Ma; Filippi, Massimo
MRI in the diagnosis of MS: expanding the concept of “no better explanation” 1-gen-2006 Charil, A; Yousry, Ta; Rovaris, M; Barkhof, F; De Stefano, N; Fazekas, F; Miller, Dh; Montalban, X; Simon, Jh; Polman, Ch; Filippi, Massimo
MRI monitoring of pathological changes in the spinal cord in patients with multiple sclerosis 1-gen-2015 Gass, A; Rocca, Ma; Agosta, F; Ciccarelli, O; Chard, D; Valsasina, P; Brooks, Jcw; Bischof, A; Eisele, P; Kappos, L; Barkhof, F; Filippi, M
Multiple sclerosis: new measures to monitor the disease 1-gen-2013 Filippi, Massimo; Rocca, Ma
Neuroimaging in amyotrophic lateral sclerosis: insights into structural and functional changes 1-gen-2014 Chiò, A; Pagani, M; Agosta, F; Calvo, A; Cistaro, A; Filippi, M
Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial. 1-gen-2014 Miller, Ae; Wolinsky, Js; Kappos, L; Comi, Giancarlo; Freedman, Ms; Olsson, Tp; Bauer, D; Benamor, M; Truffinet, P; O'Connor, Pw
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial. 1-gen-2014 Confavreux, C; O'Connor, P; Comi, Giancarlo; Freedman, Ms; Miller, Ae; Olsson, Tp; Wolinsky, Js; Bagulho, T; Delhay, Jl; Dukovic, D; Truffinet, P; Kappos, L.
Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study 1-gen-2018 Filippi, Massimo; Preziosa, Paolo; Meani, Alessandro; Ciccarelli, Olga; Mesaros, Sarlota; Rovira, Alex; Frederiksen, Jette; Enzinger, Christian; Barkhof, Frederik; Gasperini, Claudio; Brownlee, Wallace; Drulovic, Jelena; Montalban, Xavier; Cramer, Stig P; Pichler, Alexander; Hagens, Marloes; Ruggieri, Serena; Martinelli, Vittorio; Miszkiel, Katherine; Tintorè, Mar; Comi, Giancarlo; Dekker, Iris; Uitdehaag, Bernard; Dujmovic-Basuroski, Irena; Rocca, Maria A
Prevention Regimen for effectively avoiding second strokes (PRoFESS) study group 1-gen-2008 Diener, Hc; Sacco, Rl; Yusuf, S; Cotton, D; Ounpuu, S; Lawton, Wa; Palesch, Y; Martin, Rh; Alebrs, Gw; Bath, P; Bornstein, N; Chan, Bp; Chen, St; Cunha, L; Dahlof, B; DE KEYSER, J; Donnan, Ga; Estol, C; Gorelick, P; Gu, V; Teal, P; Toni, D; VANDER MAELEN, C; Voigt, T; Weber, M; Comi, Giancarlo
Progress towards a neuroimaging biomarker for amyotrophic lateral sclerosis 1-gen-2015 Filippi, M; Agosta, F; Grosskreutz, J; Benatar, M; Kassubek, J; Verstraete, E; Turner, Mr
RADIANCE Study Group. Safety and efficacy of the selective sphingosine 1-phosphate receptor modulator ozanimod in relapsing multiple sclerosis (RADIANCE): a randomized, placebo-controlled, phase 2 trial. 1-gen-2016 Cohen, Ja; Arnold, Dl; Comi, Giancarlo; Bar Or, A; Gujrathi, S; Hartung, Hp; Cravets, M; Olson, A; Frohna, Pa; Selmaj, Kw
Radiologically isolated syndrome: knowns and unknowns 1-gen-2023 Filippi, M.; Rocca, M. A.
Rethinking multiple sclerosis treatment strategies 1-gen-2020 Filippi, Massimo; Rocca, Maria A
Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis 1-gen-2017 Petzold, A; Balcer, Lj; Calabresi, Pa; Costello, F; Frohman, Tc; Frohman, Em; Martinez-Lapiscina, Eh; Green, Aj; Kardon, R; Outteryck, O; Paul, F; Schippling, S; Vermersch, P; Villoslada, P; Balk, Lj; on behalf of ERN-EYE, Imsvisual; Leocani, L
Mostrati risultati da 35 a 54 di 66
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile